Baran SEVEN | Molecular Biology | Best Paper Award

Dr. Baran Seven | Molecular Biology | Best Paper Award

Doctorate | TST Fittings and Medical Devices Industry and Trade | Turkey

Dr. Baran Seven is a committed biologist whose academic journey reflects a deep focus on toxicology, molecular biology, and environmental sciences. He earned his undergraduate, master’s, and doctoral degrees in Biology from Giresun University. His research has primarily involved investigating the toxicological effects of various chemical compounds on in vivo models, particularly Swiss albino mice. Throughout his academic progression, he has actively participated in multiple national and international scientific projects, often examining the protective effects of natural plant extracts against induced toxicities. Dr. Seven has published extensively in peer-reviewed journals and has presented his findings at numerous scientific conferences. His work demonstrates an interdisciplinary approach, blending physiological, genetic, and biochemical methods to assess and mitigate toxicity. With a strong background in both laboratory research and academic collaboration, Dr. Seven continues to contribute significantly to the fields of environmental toxicology and biomedical sciences.

Professional Profile

Scopus

Education

Dr. Baran Seven completed his entire academic training in Biology at Giresun University, Turkey. He obtained his Bachelor’s degree in 2013, followed by a Master’s degree in 2015 under the supervision of Associate Professor Kültiğin Çavuşoğlu and Professor Kürşad Yapar. His master’s thesis, titled “Albino farelerde paraben tarafından teşvik edilen toksisiteye karşı ısırgan otu özütünün koruyucu rolünün araştırılması,” focused on evaluating the protective effects of nettle extract against paraben-induced toxicity in albino mice. Continuing his studies at the same institution, he earned his Ph.D. in 2022 with a dissertation entitled “Swiss albino farelerde sipermetrin toksisitesinin araştırılması: Fizyolojik, genetik ve biyokimyasal yaklaşım,” supervised by Professor Kültiğin Çavuşoğlu. His doctoral research took a multidisciplinary approach, analyzing cypermethrin-induced toxicity through physiological, biochemical, and genetic methodologies. This comprehensive education has provided Dr. Seven with a solid foundation in experimental biology and toxicology.

Experience

Dr. Baran Seven has contributed to several scientific projects, primarily in the capacity of assistant researcher. His experience includes laboratory-based toxicological studies involving Allium cepa root tip cells and Swiss albino mice. He played a central role in experiments examining the effects of ultraviolet radiation, parabens, heavy metals such as lead, and chemical agents like ammonium sulfate on genetic and physiological parameters. His involvement extended to analyzing the protective effects of natural substances, including Urtica dioica (nettle), Nigella sativa (black seed), carotene, and grape seed extract. Dr. Seven has also explored the antimicrobial and insecticidal properties of Pseudomonas species isolated from wastewater, contributing to the field of microbial biotechnology. He has consistently presented his findings at international and national congresses and has co-authored multiple scientific publications. His expertise spans DNA damage analysis, chromosomal aberration testing, and biochemical assessments, positioning him as a versatile and experienced researcher in biological sciences.

Research Interest

Dr. Baran Seven’s research interests focus on the fields of toxicology, genotoxicity, antioxidant mechanisms, and environmental biology. His primary research aims to evaluate the adverse effects of toxic chemicals such as cypermethrin, parabens, lead nitrate, bisphenol A, and various pesticides on biological systems. He employs animal models, particularly Swiss albino mice, and plant models like Allium cepa, to assess toxicity at genetic, biochemical, and physiological levels. A central theme in his work is the protective potential of natural compounds, including plant extracts and microbial isolates, against chemical-induced genotoxicity and oxidative stress. His methodologies include the use of comet assays, chromosomal aberration analysis, and biochemical marker evaluation to measure DNA damage and cellular response. Dr. Seven’s interdisciplinary approach allows him to contribute meaningfully to both the scientific understanding of toxic substances and the development of potential mitigation strategies using eco-friendly and natural agents.

Awards and Recognition

Although specific individual awards are not explicitly listed, Dr. Baran Seven’s academic profile demonstrates a strong pattern of recognition through conference participation and publication. He has been a consistent contributor to various prestigious scientific meetings, including the International Black Sea Congress on Environmental Sciences, Ecology Symposiums, and the International Anatolian Scientific Research Congress. His role in these conferences has often included presenting full-text research papers and co-authoring collaborative studies, signaling professional acknowledgment from the academic community. Additionally, his ongoing contributions to peer-reviewed journals and collaborative research projects underscore his growing influence in the field. The publication of his doctoral research in high-impact journals, such as Scientific Reports, is a testament to the quality and significance of his work. Dr. Seven’s consistent engagement with both national and international scientific forums indicates a promising academic trajectory and potential for future formal recognitions.

Top Noted Publications

Dr. Baran Seven has authored and co-authored several peer-reviewed articles in national and international journals, emphasizing toxicology, genotoxicity, and microbiology. Key publications include:

Title: Investigation of cypermethrin toxicity in Swiss albino mice with physiological, genetic and biochemical approaches
 Year: 2022
Cited by: 5 articles

Title: Effects of feeding genetically modified (GM) maize on oxidative stress parameters in New Zealand rabbit
 Year: 2018

Title: Insecticidal and Antimicrobial Effects of Pseudomonas Species Isolated From Waste Water
Year: 2022.

Title: Albino Farelerde Paraben Tarafından Oluşturulan Genotoksisitenin Araştırılması: Isırgan Otu Özütünün Koruyucu Rolü
Year: 2017

Conclusion

Dr. Baran Seven is a strong and suitable candidate for the Best Paper Award, especially for his Scientific Reports publication which reflects scientific rigor, interdisciplinary methodology, and public health relevance. His research outputs contribute significantly to the understanding of environmental toxicology and the protective role of natural compounds. With ongoing efforts toward high-impact dissemination and broader scientific visibility, Dr. Seven is poised to make continued valuable contributions to the field.

Maria Yavropoulou | microRNAs | Best Researcher Award

Dr. Maria Yavropoulou | microRNAs | Best Researcher Award 

Doctorate, at Medical School, National and Kapodistrian University of Athens, LAIKO University Hospital of Athens, Greece.

Dr. Maria Yavropoulou is an accomplished Endocrinology Consultant at the Endocrinology Unit of the 1st Department of Propaedeutic and Internal Medicine at the Medical School of the National and Kapodistrian University of Athens (NKUA), based in LAIKO University Hospital, Athens. With a career spanning clinical practice, research, and teaching, she specializes in rare endocrine disorders, particularly calcium and phosphate metabolism. Dr. Yavropoulou’s dedication to endocrine research has resulted in over 133 publications, earning 3,430 citations. Her international training, expertise in bone metabolism, and leadership roles in specialized endocrine centers highlight her contribution to the field.

Profile

Scopus

Google Scholar

ORCID

Education 🎓

Dr. Yavropoulou earned her Medical Degree from Aristotle University of Thessaloniki (AUTh) and specialized in Endocrinology at AHEPA University Hospital. She advanced her expertise with specialized training in the Netherlands (LUMC) and the USA (UAMS), focusing on bone metabolism under esteemed mentors. Dr. Yavropoulou holds a Ph.D. in diseases affecting bone metabolism from AUTh and two Master’s Degrees: one in “Translational Research in Molecular Biology and Genetics” and another in “Epidemiology – Research Methodology in Biomedical Sciences” from NKUA. Her multidisciplinary education underpins her impactful research in endocrinology.

Experience 🏥

Dr. Yavropoulou has extensive experience managing endocrine diseases, emphasizing rare calcium and phosphate metabolism disorders. As Deputy Head of the Center for Expertise of Rare Disorders of Calcium and Phosphate Metabolism (C.E.R.E.D.) since 2019, she leads specialized care. She also coordinates quality for the Adult Langerhans Histiocytosis Center. Her tenure includes roles in clinical, translational research and leadership positions within the European Society of Endocrinology (ESE).

Research Interests 🔬

Dr. Yavropoulou focuses on bone metabolism, diabetes, and endocrine implications on systemic health. Her work integrates clinical and molecular approaches, exploring topics such as transgenic models, cortisol production, and endocrine-related immune system interactions. Her meta-analytical studies provide insights into treatment compliance and endocrine therapies.

Awards 🏆

Dr. Yavropoulou’s accolades include the Jens Sandahl Christiansen Award (2020, ESE) and the G. TOLIS Award (2019, HES). She has received multiple national and European honors for her basic and clinical research contributions, including the inaugural 2022 EJE Rising Star Award by the European Journal of Endocrinology. Her excellence has also been recognized with scholarships and grants from esteemed organizations like the Hellenic Society for the Study of Bone Metabolism.

Top Notes Publications 📚

Here are some of Dr. Yavropoulou’s notable recent publications:

1. The Association of Vitamin D Receptor Polymorphisms with COVID-19 Severity

Journal: Nutrients, 2024
Key Highlights:

  • Investigates the role of polymorphisms in the Vitamin D receptor (VDR) gene in determining the severity of COVID-19.
  • Findings suggest that certain VDR polymorphisms may influence the immune response and inflammation during COVID-19 infection.
  • Highlights the potential of personalized medicine approaches to mitigate COVID-19 severity by addressing VDR-related pathways.
    Read more

2. Diurnal Production of Cortisol in Rheumatoid Arthritis

Journal: RMD Open, 2024
Key Highlights:

  • Explores the daily fluctuation of cortisol levels in patients with rheumatoid arthritis (RA).
  • The study links disrupted cortisol patterns to increased disease activity and pain levels in RA patients.
  • Suggests therapeutic interventions targeting cortisol rhythms to alleviate symptoms.
    Read more

3. Transient Osteoporosis of the Hip after Denosumab Discontinuation

Journal: Osteoporos Int, 2024
Key Highlights:

  • Reports cases of transient osteoporosis of the hip following the discontinuation of denosumab, an anti-resorptive therapy.
  • Discusses the rebound effect in bone turnover and the need for careful management post-treatment.
  • Recommends alternative therapies to mitigate risk.
    Read more

4. Nocebo-Associated Discontinuation with Subcutaneous Anti-Osteoporotic Drugs

Journal: Maturitas, 2024
Key Highlights:

  • Examines the role of nocebo effects (negative expectations) in the discontinuation of subcutaneous anti-osteoporotic drugs.
  • Highlights the importance of patient education and communication to reduce nocebo-associated discontinuation rates.
  • Suggests strategies for improving adherence to osteoporosis treatment.
    Read more

5. Immune System Effects on the Endocrine System

Journal: Endotext, 2023
Key Highlights:

  • Comprehensive review of the interactions between the immune system and the endocrine system.
  • Focuses on how immune dysregulation can lead to endocrine disorders, including thyroid dysfunction and adrenal insufficiency.
  • Discusses implications for treating autoimmune and inflammatory diseases.
    Read more

Conclusion

Dr. Maria Yavropoulou is a highly deserving candidate for the Research for Best Researcher Award. Her exceptional achievements in clinical and basic endocrinology research, leadership in international academic societies, and contributions to understanding rare metabolic disorders position her as a distinguished figure in her field. Addressing minor areas of improvement could further elevate her already outstanding career. She exemplifies the qualities of a world-class researcher, and her work continues to significantly impact endocrinology and related disciplines.